EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Artificial intelligence–assisted oculo‐gait measurements for cognitive impairment in cerebral small vessel disease

Huimin Chen, Hao Du, Fang Yi, Tingting Wang, Shuo Yang, Yuesong Pan, Hongyi Yan, Dandan Liu, Mengyuan Zhou, Yiyi Chen, Mengxi Zhao, Jingtao Pi und 8 weitere

Alzheimer's & Dementia · 2024-12 · 20 (12) · 8516-8526

DOI: 10.1002/alz.14288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 16.10.2024. Verfasst von Huimin Chen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Dong…. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Artificial Intelligence, Cognitive Dysfunction. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Outstanding Young Scientist Program, Capital Funds for Health Improvement and Research, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Oculomotor and gait dysfunctions are closely associated with cognition. However, oculo‐gait patterns and their correlation with cognition in cerebral small vessel disease (CSVD) remain unclear. METHODS Patients with CSVD from a hospital‐based cohort ( n = 194) and individuals with presumed early CSVD from a community‐based cohort ( n = 319) were included. Oculo‐gait patterns were measured using the artificial intelligence (AI) –assisted ‘EyeKnow’ eye‐tracking and ‘ReadyGo’ motor evaluation systems. Multivariable linear and logistic regression models were employed to investigate the association between the oculo‐gait parameters and cognition. RESULTS Anti‐saccade accuracy, stride velocity, and swing velocity were significantly associated with cognition in both patients and community dwellers with CSVD, and could identify cognitive impairment in CSVD with moderate accuracy (area under the curve [AUC]: hospital cohort, 0.787; community cohort, 0.810) after adjusting for age and education. DISCUSSION The evaluation of oculo‐gait features (anti‐saccade accuracy, stride velocity, and swing velocity) may help screen cognitive impairment in CSVD. Highlights Oculo‐gait features (lower anti‐saccade accuracy, stride velocity, and swing velocity) were associated with cognitive impairment in cerebral small vessel disease (CSVD). Logistic model integrating the oculo‐gait features, age, and education level moderately distinguished cognitive status in CSVD. Artificial intelligence–assisted oculomotor and gait measurements provide quick and accurate evaluation in hospital and community settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Small Vessel DiseasesArtificial IntelligenceCognitive DysfunctionHumansFemaleMaleAgedCohort StudiesGaitMiddle AgedNeuropsychological Tests

Stichwörter der Autor:innen

artificial intelligencecerebral small vessel diseasecognitioneye trackinggait

Autor:innen und Institutionen

  • Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Dongcheng, Beijing, China.
  • Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Geriatric Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Fengtai, Beijing, China.
  • China National Clinical Research Center for Neurological Diseases, Fengtai, Beijing, China.

Förderung

  • Beijing Outstanding Young Scientist Program
  • Capital Funds for Health Improvement and Research
  • National Key R&D Program of China
  • Youth Beijing Scholar Program
  • Beijing Laboratory of Oral Health
  • Beijing Talent, Project - Class A: Innovation and Development
  • National Ten-Thousand Talent Plan
  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Du, H., Yi, F., Wang, T., Yang, S., Pan, Y., Yan, H., Liu, D., Zhou, M., Chen, Y., Zhao, M., Pi, J., Yang, Y., Fan, X., Cai, X., Qiu, Z., Zhang, J., Liu, Y., Gu, W., & Wang, Y. (2024). Artificial intelligence–assisted oculo‐gait measurements for cognitive impairment in cerebral small vessel disease. Alzheimer's & Dementia, 20(12), 8516-8526. https://doi.org/10.1002/alz.14288

Vancouver

Chen H, Du H, Yi F, Wang T, Yang S, Pan Y, et al. Artificial intelligence–assisted oculo‐gait measurements for cognitive impairment in cerebral small vessel disease. Alzheimer's & Dementia. 2024;20(12):8516-8526. doi:10.1002/alz.14288

BibTeX
@article{Chen2024,
  author = {Chen, Huimin and Du, Hao and Yi, Fang and Wang, Tingting and Yang, Shuo and Pan, Yuesong and Yan, Hongyi and Liu, Dandan and Zhou, Mengyuan and Chen, Yiyi and Zhao, Mengxi and Pi, Jingtao and Yang, Yingying and Fan, Xiangmin and Cai, Xueli and Qiu, Ziyu and Zhang, Jipeng and Liu, Yawei and Gu, Wenping and Wang, Yilong},
  title = {Artificial intelligence–assisted oculo‐gait measurements for cognitive impairment in cerebral small vessel disease},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {12},
  pages = {8516--8526},
  doi = {10.1002/alz.14288}
}
Kostenlos starten →